期刊文献+

箭叶淫羊藿中化学成分及其体外抗肿瘤活性研究 被引量:15

Chemical constituents in Epimedium sagittatum and their in vitro antitumor activities
原文传递
导出
摘要 目的分离箭叶淫羊藿中的化学成分并对8-异戊烯基黄酮类化合物进行体外抗肿瘤活性筛选。方法采用硅胶柱色谱、凝胶柱色谱和HPLC制备色谱方法分离纯化,根据理化性质和波谱分析方法鉴定其结构,利用MTT法对分离得到的异戊烯基黄酮类化合物进行体外抗肿瘤活性筛选。结果分离得到7个黄酮类化合物,分别鉴定为淫羊藿苷(1)、淫羊藿素(2)、宝藿苷Ⅰ(3)、去甲淫羊藿素(4)、苜蓿素(5)、淫羊藿次苷Ⅰ(6)和朝藿定C(7)。体外抗肿瘤结果表明,在0.5~100μmol/L浓度,化合物2、3、4、6对人乳腺癌MDA-MB-231细胞增殖具有明显抑制作用,并随浓度的增加抑制作用更加明显,48h的IC50分别为12.43、35.44、11.53、16.31μmol/L,化合物1、7活性很弱。结论化合物3、4为首次从箭叶淫羊藿植物分离得到,化合物3有望成为靶向抗乳腺癌的候选药物。 Objective To investigate the chemical constituents from Epimedium sagittatum and screen in vitro antitumor activity for 8-prenylated flavonoids.Methods Chemical constituents were isolated and purified by chromatography on silica gel,Sephadex LH-20 colums,and preparative HPLC.Their structures were identified by physicochemical constants and spectroscopic methods.The in vitro antitumor activities of the isolated prenylated compounds were evaluated by MTT assay.Results Seven flavonoids were isolated and their structures were identified as icariin(1),icaritin(2),baohuosideⅠ(3),desmethylicaritin(4),tricin(5),IcarisideⅠ(6),and epimedin C(7).In vitro antitumor results showed that compounds 2-4 and 6 showed the enhanced inhibition on the cell proliferation of human breast cancer cell line MDA-MB-231 in 0.5 — 100 μmol/L with concentration increasing.The IC50 value for 48 h was 12.43,35.44,11.53,and 16.31 μmol/L respectively,the activity of compound 1 and 7 were very weak.Conclusion Compounds 3 and 4 are isolated from E.sagittatum for the first time.Compound 3 is expected to become one of the anti-breast cancer drug candidates.
出处 《现代药物与临床》 CAS 2013年第3期269-273,共5页 Drugs & Clinic
基金 国家重大新药创制科技重大专项(2009ZX09102)
关键词 箭叶淫羊藿 8-异戊烯基黄酮 宝藿苷Ⅰ Epimedium sagittatum(Sieb.et Zucc.)Maxim. 8-prenylated flavonoids baohuosideⅠ
  • 相关文献

参考文献17

  • 1尹剑云,陈红风.淫羊藿及其有效成分抗肿瘤机制的研究进展[J].中西医结合学报,2009,7(12):1184-1187. 被引量:10
  • 2Li Y, Yao J, Chang M, et al. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase [J]. Chem Res Toxicol, 2004, 17(4): 512-520.
  • 3Nilsson S, Gustafsson J A. Estrogen receptor action [J]. Crit Rev Eukaryot Gene Expr, 2002, 12(4): 237-257.
  • 4Wang Z, Zhang X, Shen P, et al. A variant of estrogen receptor- {alpha} , hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated rnitogenic signaling [J]. Proc Natl Acad Sci USA, 2006. 103(24): 9063-9068.
  • 5Shi L, Dong B, Li Z, et al. Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer [J]. J Clin Oncol, 2009, 27(21): 3423-3429.
  • 6Siegelmann-Danieli N, Kurnik D, Lornnicky Y, et al. Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen [J]. Breast Cancer Res Treat, 2011, 125(2): 505-510.
  • 7单淇,周渭渭,周福军,侯文彬.阿可拉定的有关物质研究[J].药物评价研究,2011,34(2):92-95. 被引量:6
  • 8Mizuno M, Kanie Y, Iinuma M, et al. Two flavonol glycosides from Vancouveria hexandra [J]. Phytochemistry, 1992, 31(1): 297-299.
  • 9李枫 刘永隆.宝藿甙-Ⅰ,Ⅵ,Ⅶ和宝藿素的分离和结构研究[J].药学学报,1988,23(10):739-748.
  • 10Fukai T, Nomura T. ^1H-NMR chemical shift of the flavonol 5-hydroxy proton as a characterization of 6-or 8-isoprenoid substitution [J]. Heterocycles, 1992. 34(6): 1213-1225.

二级参考文献41

共引文献77

同被引文献247

引证文献15

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部